| Literature DB >> 27809220 |
David W Severson1, Susanta K Behura2.
Abstract
Dengue (DENV), yellow fever, chikungunya, and Zika virus transmission to humans by a mosquito host is confounded by both intrinsic and extrinsic variables. Besides virulence factors of the individual arboviruses, likelihood of virus transmission is subject to variability in the genome of the primary mosquito vector, Aedes aegypti. The "vectorial capacity" of A. aegypti varies depending upon its density, biting rate, and survival rate, as well as its intrinsic ability to acquire, host and transmit a given arbovirus. This intrinsic ability is known as "vector competence". Based on whole transcriptome analysis, several genes and pathways have been predicated to have an association with a susceptible or refractory response in A. aegypti to DENV infection. However, the functional genomics of vector competence of A. aegypti is not well understood, primarily due to lack of integrative approaches in genomic or transcriptomic studies. In this review, we focus on the present status of genomics studies of DENV vector competence in A. aegypti as limited information is available relative to the other arboviruses. We propose future areas of research needed to facilitate the integration of vector and virus genomics and environmental factors to work towards better understanding of vector competence and vectorial capacity in natural conditions.Entities:
Keywords: Aedes aegypti; dengue virus; functional genomics; genetic control; innate immunity; integrative approach; mosquito arbovirus interaction; transcriptome; vector competence
Year: 2016 PMID: 27809220 PMCID: PMC5198206 DOI: 10.3390/insects7040058
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Figure 1Physical chromosome locations of anchor markers for QTL conditioning vector competence to DENV-2, the protozoan parasite Plasmodium gallinaceum, and the metazoan parasite Brugia malayi. Adapted from [77].
Figure 2DENV infection and replication cycle in A. aegypti. Compiled from [69,79,83,84].
Broad-scale transcriptome assays of the innate immune response of Aedes aegypti to dengue virus infection.
| Study | Strain Susceptibility | Dengue Strain 3 | Mosquito Infection | Sample Point(s) Post-Infection and Tissues | Transcriptome Assay | |
|---|---|---|---|---|---|---|
| [ | Rockefeller | Susceptible 1 | A | oral | 10 days, midgut | Agilent microarrays |
| 10 days, carcass | ||||||
| [ | Rockefeller | Susceptible | A | oral | 3 days, 7 days, whole body | Agilent microarrays |
| [ | Cali | Susceptible | A | oral | 48 h, midgut | Suppressive subtractive hybridization |
| Cali | Refractory | |||||
| [ | Rockefeller | Susceptible | A | injection | 1 day, 2 days, 7 days, whole body | NimbleGen |
| [ | Moyo-R | Refractory | B | oral | 3 h, 18 h, whole body | NimbleGen |
| Moyo-S | ||||||
| [ | Moyo-D | Refractory | B | oral | 1 h, 4 h, 1 day, 2 days, 4 days, midgut | Custom cDNA microarrays |
| Moyo-S | ||||||
| [ | Chetumal | Susceptible | B | oral | 1 day, 4 days, midgut | Illumina, RNA-Seq |
| 14 days, salivary glands | ||||||
| 1 day, 4 days, 14 days, carcass | ||||||
| [ | Rockefeller | Susceptible | A | oral | 14 days, salivary glands | Agilent microarrays |
| 14 days, carcass | ||||||
| [ | Rockefeller | High 2 | A | oral | 7 days, midgut | Agilent microarrays |
| Orlando | Low | 7 days, carcass | ||||
| Waco | Low | |||||
| Puerto Rico | Intermediate | |||||
| Saint Kitts | Intermediate | |||||
| Por Fin | Intermediate | |||||
| Puerto Triunfo | High | |||||
| Singapore | High | |||||
| Bangkok | Low | |||||
| [ | D2S3 | Susceptible | B | oral | 3 h, 3 days, midgut | Custom cDNA microarrays |
| Moyo-D | Refractory |
1 Susceptible vs. refractory status based on dissemination from the midgut; 2 High, intermediate, low status based on midgut titers relative to Rockefeller strain; 3 A = DENV-2 New Guinea C, B = DENV-2 JAM 1409.